Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.
about
MicroRNAs in glioblastoma multiforme pathogenesis and therapeuticsNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesThe Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell LinesThe Effects of Antisense miRNA-20a Alone or in Combination with Imatinib on K562 Cell ProliferationOverexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growthA Systemic Analysis of Transcriptomic and Epigenomic Data To Reveal Regulation Patterns for Complex DiseaseAldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis.Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancerCirculating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.Lower MGMT expression predicts better prognosis in proneural-like glioblastomamiRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cellsA five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patientsEMMPRIN Down-regulating miR-106a/b Modifies Breast Cancer Stem-like Cell Properties via Interaction with Fibroblasts Through STAT3 and HIF-1α.Oncogenic role of microRNA‑20a in human uveal melanoma.microRNA-20a Inhibits Autophagic Process by Targeting ATG7 and ATG16L1 and Favors Mycobacterial Survival in Macrophage Cells.A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics.miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.Pilot Study of Whole Blood MicroRNAs as Potential Tools for Diffuse Low-Grade Gliomas Detection.Biological effects and clinical characteristics of microRNA-106a in human colorectal cancer.TIMPs: versatile extracellular regulators in cancer.miR-4299 mediates the invasive properties and tumorigenicity of human follicular thyroid carcinoma by targeting ST6GALNAC4.Inhibition of miR-630 enhances the cell resistance to radiation by directly targeting CDC14A in human gliomaNDGA-P21, a novel derivative of nordihydroguaiaretic acid, inhibits glioma cell proliferation and stemness.MicroRNA-27b inhibits Spry2 expression and promotes cell invasion in glioma U251 cells.Low-Dose Endothelial-Monocyte-Activating Polypeptide-II Induced Autophagy by Down-Regulating miR-20a in U-87 and U-251 Glioma Cells.microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinasesSerum microRNA profiling in patients with glioblastoma: a survival analysis.Oncogenic role of microRNA-20a in human multiple myeloma.Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells (Review).Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2.Research on human glioma stem cells in China.Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling.Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance.The miR-17-92 cluster/QKI2/β-catenin axis promotes osteosarcoma progression.VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cellsConnexin 43 C-terminus directly inhibits the hyperphosphorylation of Akt/ERK through protein-protein interactions in glioblastomaUltrasound microbubbles mediated miR-let-7b delivery into CD133 ovarian cancer stem cells
P2860
Q26747273-910818F1-9B21-49E8-A34D-C4B163882FEDQ26748881-30B96209-3346-4C59-962D-D4613C2CFDC6Q28547067-E0AE4F26-DF91-42BE-A0E6-9C0F9B8D2F20Q32179310-DA05C6DB-2129-4B6A-8698-1D61703C2D0BQ33648713-07DD30D1-1CBC-43D3-A319-D2613D05F97AQ33770873-B0346544-7F31-415A-9970-704787B3E84AQ33877366-CA784176-2531-4297-96EA-D5A08D22F728Q35758016-84E59E3F-0A66-4DF7-9B09-6039F42C7952Q36140898-2A35099B-2F76-422E-B7EE-6130A9822030Q36245788-F7001D93-9CE6-40D5-B881-0ACF95E4EBB1Q36294437-F6C1B212-6631-45B9-976C-E7743B8079E2Q36492682-0A9AE049-BBB4-4886-8391-AE59630AF169Q36545899-4245335A-A337-4EA3-ACF6-6CDBE3D36507Q36557284-7035B3A6-4BC1-446E-A211-87246CAE5F5CQ37023781-A53CD40A-009B-4047-843D-FE457DC283D8Q37082920-55632D87-5D66-47AF-AF5D-CFDD1585FF3AQ37345091-6F14D50A-7D81-443A-9642-609D71251B31Q37636717-3D835993-E997-45FA-8D15-39E384EAE9A0Q37687490-6DB33081-0CD3-4943-8209-1CD6D6433A03Q38621047-C9115512-A28F-4EF0-9007-8C809E638E4DQ38686015-418D9510-0E82-4105-B351-9607624C2D78Q38785433-2504C2E1-E9CE-4578-8526-DBE84EF8B20CQ38808151-AC00B32A-6B9C-4A2F-B367-0712D32A9A4EQ38848860-D8006D49-4D52-46D8-B1FD-EB6A895E5914Q40201358-E36C35A2-0CE6-48AA-8E0C-BEAF94033893Q41461370-37B6CB9C-5A4A-4548-8922-A6AC5E7379FAQ41860362-963D1B6B-5D80-4714-8155-6007A4939727Q42002108-5740B274-2C54-429D-B077-4B457D4C6DFBQ42317085-9F9B4F54-FF1A-46DC-821D-EFA448044C3EQ42360156-4689BAE0-A4F0-4502-8B56-0D15DCD04119Q47102900-EF533909-9507-4000-AD16-A28467BF4EABQ47122552-16604F74-2722-4C6C-B616-1E11FC1B68F6Q47140045-D4EB7E99-77B7-4606-A95A-DA0BE9664847Q47151420-44FFE9C1-BC80-4A46-A301-A5E68A2BAC32Q48198419-1E94AF19-7B14-457D-B919-D5861CBC4B89Q49945042-F02AE873-563D-47E3-AA34-3E5393878D05Q55078467-7C5526E4-7659-41B4-97BD-D3FE10B136A3Q58700437-8C5C3E19-84FA-44D9-A295-2B0DE6C6B1A5Q58792718-0051ECB1-71F8-41A7-8BCB-8AC68ABE881FQ59125981-A31319AF-113A-476A-A240-3CBDF46D5DA9
P2860
Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Oncogenic miR-20a and miR-106a ...... by directly targeting TIMP-2.
@en
Oncogenic miR-20a and miR-106a ...... by directly targeting TIMP-2.
@nl
type
label
Oncogenic miR-20a and miR-106a ...... by directly targeting TIMP-2.
@en
Oncogenic miR-20a and miR-106a ...... by directly targeting TIMP-2.
@nl
prefLabel
Oncogenic miR-20a and miR-106a ...... by directly targeting TIMP-2.
@en
Oncogenic miR-20a and miR-106a ...... by directly targeting TIMP-2.
@nl
P2093
P2860
P356
P1433
P1476
Oncogenic miR-20a and miR-106a ...... by directly targeting TIMP-2.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2014.75
P407
P577
2014-04-07T00:00:00Z